(Press-News.org) WASHINGTON, April 2, 2024 – Hydrogels are popular for use in skin ailments and tissue engineering. These polymer-based biocompatible materials are useful for their abilities to retain water, deliver drugs into wounds, and biodegrade. However, they are complicated to manufacture and not very resilient to external forces like rubbing against clothing, sheets, or wound dressings. They are also not inherently able to battle bacterial infections, so they are often infused with antimicrobial drugs or metal ions, which can cause antibiotic resistance and negative effects on cell growth.
In a paper published this week in APL Materials, by AIP Publishing, researchers created a hydrogel that is easier to synthesize, contains natural antibiotic properties, and promotes cell growth.
“A diabetic patient may have skin wounds that do not heal easily due to metabolic disease,” author Jing Sun said. “The patient may try to treat the wounds with topical medicines such as erythromycin, and it may be effective at first, but over a long period of time, it may fail to relieve symptoms. This could be due to antibiotic resistance.”
Using the common hydrogel Gel-MA, they added the amino acid polylysine and platelet-rich blood plasma to create properties that are well-suited to wound care. The result is a hydrogel that is stronger, expands in the wound, lasts longer, kills bacteria, and creates a healthy environment for new cells to grow.
“The hydrogel continuously releases polylysine on the wound surface and continuously inhibits bacterial growth,” Sun said. “We chose ε-polylysine because it can inhibit the growth of bacteria and solve the problem of antibiotic abuse, drug resistance, and does not affect the proliferation and development of cells. It can also conjugate with gelatin methacrylate, which plays an antimicrobial role and enhances the mechanical strength of the hydrogel.”
In tests with E. coli and S. aureus, the bacterium that causes staph infection, the hydrogel damaged bacteria cell membranes and led to bacterial cell death. For healthy cells, the inclusion of platelet-rich blood plasma resulted in a release of growth factors and an increase of viable cells.
“The most interesting and exciting moment for me was when we mixed the polylysine and platelet-rich plasma solutions to see if they could form a hydrogel under UV irradiation,” Sun said.
The experiment worked, and the hydrogel can be cured under a UV lamp for 30 seconds instead of curing by repeatedly freezing and thawing for up to 8 hours.
“As a clinician and researcher in dermatology, I have the obligation to provide better treatments for patients,” Sun said. “Patients with chronically infected wounds combined with metabolic diseases, such as diabetes, malnutrition, and other diseases, as well as long-term bedridden patients will be helped by this solution.”
###
The article, "Methacrylated Gelatin Hydrogel Conjugated with ε-Polylysine and Enriched with Platelet-Rich Plasma for Chronically Infected Wounds," is authored by Peiyu Yan, Xiangru Chen, Xin He, Zhaoyang Liu, and Jing Sun. It will appear in APL Materials on April 2, 2024 (DOI: 10.1063/5.0200159). After that date, it can be accessed at https://www.doi.org/10.1063/5.0200159.
ABOUT THE JOURNAL
APL Materials is an open access journal that features original research on significant topical issues within all areas of materials science. See https://aip.scitation.org/journal/apm
###
END
Wound treatment gel fights the battle against antibacterial resistance
Hydrogel infused with amino acid kills bacteria naturally and promotes cell growth.
2024-04-02
ELSE PRESS RELEASES FROM THIS DATE:
Finding the connective tissue of soft materials
2024-04-02
The human body uses adhesion to hold itself together. For example, a tendon attaches muscle to bone, while connective tissue attaches muscle to skin.
Hydrogel-based soft materials are based on these biomimetic mechanical behaviors, which makes them a revolutionary design of biomedical implants, human-machine interfaces, and bio-inspired soft robots. However, there are limitations to overcome before they are able to fully replace commonly used hard materials.
Qihan Liu, assistant professor of mechanical and materials ...
Scientists link certain gut bacteria to lower heart disease risk
2024-04-02
Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers at the Broad Institute of MIT and Harvard along with Massachusetts General Hospital has found that microbes in the gut may affect cardiovascular disease as well. In a study published in Cell, the team has identified specific species of bacteria that consume cholesterol in the gut and may help lower cholesterol and heart disease risk in people.
Members of Ramnik Xavier’s lab, Broad’s Metabolomics Platform, and ...
Gene analysis generates spatial map of intestinal cells and traces their trajectories during gut inflammation
2024-04-02
Cells within the intestines perform various roles including nutrient absorption, sensing, and maintaining homeostasis. Certain chronic disorders are distinctly characterized by gut inflammation, which disrupts intestinal cells and can lead to a remodeling of the gut and the introduction of new immune cells. To better understand the types of cells and their positioning within the intestines, researchers at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, in collaboration with investigators ...
Gloom and doom warnings about climate change do not work
2024-04-02
If you want to spread a message about climate change and global warming, you need to adapt the message according to your intended audience and what you want to achieve.
Researchers have now developed an app to help people who want to spread their message on climate issues to ensure they generate the most support possible – be they researchers, politicians, various decision makers or legislators.
Huge survey involving 63 countries
59,000 people participated in surveys as part of the work on creating the app, and Norway was among ...
The 2024 Career Optimism Index® study highlights shift from the great resignation to a great talent stagnation – and how employers can break through
2024-04-02
Today the University of Phoenix Career Institute® released its 2024 Career Optimism Index®, a comprehensive study examining the state of American workers' career trajectories and sentiments about the future of their job and career opportunities. This year's Index, the fourth consecutive year it has been fielded, reveals that workers and employers are facing a critical moment of talent stagnation in the workplace.
More than half (53%) of Americans report feeling easily replaceable in their job position and 64% of workers say their company does not offer opportunities ...
Minimally invasive procedure may spare patients from thyroid surgery
2024-04-02
OAK BROOK, Ill. – In a 10-center study, microwave ablation offered progression free survival rates and fewer complications than surgery in the treatment of a form of thyroid cancer known as papillary thyroid carcinoma (PTC), according to research published today in Radiology, a journal of the Radiological Society of North America (RSNA).
The most common type of thyroid cancer, PTC often presents with multifocality, meaning that two or more bumps or nodules (papillae) are found within the thyroid gland. The occurrence of multifocality within PTC cases is notably frequent, ranging between approximately ...
Noted UCLA neurologist Dr. Rhonda Voskuhl wins 2024 John Dystel Prize for multiple sclerosis research
2024-04-02
[New York, April 2, 2024] – Rhonda Voskuhl, M.D., an internationally recognized neurologist and investigator at the University of California, Los Angeles, is the winner of the 2024 John Dystel Prize for Multiple Sclerosis Research. She is being recognized for her innovative research to understand mechanisms underlying sex differences in multiple sclerosis (MS) and advancing women’s health.
Women are much more susceptible than men to developing MS, an immune-mediated neurological disease. Voskuhl has conducted extensive basic and clinical research ...
Novel vaccine, PfSPZ-LARC2 Vaccine, to prevent malaria infection developed by Seattle Children’s Research Institute and Sanaria ready for human testing
2024-04-02
April 2, 2024 – In a report published on March 21, 2024 in EMBO Molecular Medicine (A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion) investigators at Seattle Children’s Research Institute and Sanaria Inc. describe the development of a whole malaria parasite vaccine strain that infects the liver, develops to the late liver stage, and then gets completely stuck and cannot burst out of the liver to cause symptomatic blood infection. The creation of this strain called LARC2 (Late liver-stage Arresting, Replication Competent) was accomplished by deletion of only two parasite genes out of the approximately 5,000 in the ...
A hybrid data driven framework considering feature extraction for battery state of health estimation and remaining useful life prediction
2024-04-02
A paper proposing a hybrid data driven framework considering feature extraction for battery state of health estimation and remaining useful life prediction was published in the journal Green Energy and Intelligent Transportation on 29 March 2024.
VMD is used for completely non-recursive modal variation to deal with signals. The optimal solution of the variational problem is obtained finally by effective decomposition component of the given signal. By iteration, the VMD algorithm can decompose the signals into some intrinsic ...
Press passes available now for NUTRITION 2024 to be held June 29–July 2
2024-04-02
Complimentary press passes are now available for NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition. Join us June 29–July 2 in Chicago for the latest developments in nutrition research, practice and policy.
As the pre-eminent meeting in nutrition science, NUTRITION attracts thousands of scientists, practitioners, policymakers, advocacy leaders and industry professionals each year. Reporters are invited to attend in person to connect with the field’s leaders and learn about exciting scientific ...
LAST 30 PRESS RELEASES:
Risk of secondary cancers after CAR T therapy may be similar to risk after other cancer treatments
Enhance and revise for better low-light image enhancement
Multiple ways to evolve tiny knee bone could have helped humans walk upright
UBCO study explores access to psychedelics for therapeutic use
Lower diligence level linked to higher cardiovascular disease risk in type 2 diabetes
Statins cost effective and linked to better health outcomes in older people
Abdominal fat linked to widespread chronic pain, especially in women
Wearable brain imaging device shines a light on how babies respond in real-world situations
"Cuddle hormone" oxytocin may provide pain relief and help curb harmful opioid use
Study reveals mechanism that activates glucose production in the liver in response to stress
Aumolertinib maintenance after chemoradiotherapy in stage III non-small cell lung cancer improves PFS compared to placebo
Weight loss of up to 13% achieved in three months with once-a-day tablet, phase 1 trial finds
Time-restricted eating improves blood sugar control in adults at risk of type 2 diabetes regardless of time of day
Individuals with complications of diabetes are at higher risk of gum disease, Danish study finds
Weight loss drug liraglutide is safe and effective in children under 12, study finds
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
The glug of it all
UTA to build netted drone facility in Fort Worth
Streamlining energy regulations on Native American reservations could help alleviate poverty
UT microbiologist Wilhelm honored as Fellow of the Royal Society of Canada
NCCN Policy Summit explores how to build an inclusive cancer center workplace culture that better serves everybody
Games, puzzles and reading can slow cognitive decline in the elderly — even in those with mild cognitive impairment
An antidiabetic helps the immune system recognize reservoirs of HIV
Department of Energy grant advances clean energy studies
Finding the right path(way) to reduce fat accumulation in the liver
MicroDicer and MicroGrater make quick work of tumor dissection
Phase II study of taletrectinib shows clinically meaningful overall response and favorable safety in patients with ROS1+ non-small cell lung cancer
LUMINOSITY trial demonstrates telisotuzumab vedotin shows durable response in Asian patients with c-Met protein-overexpressing EGFR WT nonsquamous NSCLC
PM2.5 exposure may affect lung cancer in women who have never smoked
Results from CARMEN-LC03 phase 3 study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC presented at WCLC 2024
[Press-News.org] Wound treatment gel fights the battle against antibacterial resistanceHydrogel infused with amino acid kills bacteria naturally and promotes cell growth.